Company attributes
B2X
CEO
Date Incorporated
June 18, 2013
Number of Employees (Ranges)
201 – 500
Email Address
research@medgenome.com0
Phone Number
+188844009540
Full Address
108 West 13th Street Wilmington Delaware 19801, County of New Castle, USA0
348 Hatch Drive Foster City, CA 94404 United States0
Investors
DUNS Number
078837694
Founded Date
2013
Total Funding Amount (USD)
169,000,000
Latest Funding Round Date
August 30, 2022
Competitors
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
50,000,000
MedGenome specializes in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology and rare diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
